Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy
- 1 September 2010
- journal article
- research article
- Published by Elsevier BV in HPB
- Vol. 12 (7), 447-455
- https://doi.org/10.1111/j.1477-2574.2010.00196.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the PancreasAnnals of Surgery, 2010
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009
- Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trialsBritish Journal of Cancer, 2009
- Results of Pancreaticoduodenectomy in Patients With Periampullary AdenocarcinomaAnnals of Surgery, 2008
- Delayed Recovery after Pancreaticoduodenectomy: A Major Factor Impairing the Delivery of Adjuvant Therapy?Journal of the American College of Surgeons, 2007
- Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stromaSurgery, 2006
- Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patientsSurgery, 2006
- Pancreatic cancer: surgery alone is not sufficientSurgical Endoscopy, 2006
- Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgery, 2004
- Intraductal papillary‐mucinous neoplasms of the pancreasCancer, 2001